Please enable JavaScript
Powered by Benchmark Matribhumi Samachar English - Page 807 of 2911 -
Monday, February 23 2026 | 08:35:39 PM

ALUULA Reports Third Quarter 2025 Financial Results

ALUULA delivers on broader market growth and announces leadership change Victoria, British Columbia–(Newsfile Corp. – September 23, 2025) – ALUULA Composites Inc. (TSXV: AUUA) (“ALUULA” or the “Company“) today reported its financial results for the three and nine month periods ended July 31, 2025 (“Q3 2025” and “YTD Q3 2025” …

Read More »

CSE Bulletin: Delist – GameOn Entertainment Technologies Inc. (GET)

Toronto, Ontario–(Newsfile Corp. – Le 23 septembre/September 2025) – The common shares of GameOn Entertainment Technologies Inc. will be delisted from the CSE at market close today, September 23, 2025. GameOn Entertainment Technologies is currently suspended. See Bulletin 2024-1213. _________________________________ Les actions ordinaires de GameOn Entertainment Technologies Inc. seront retirées …

Read More »

Benton Increases Private Placement to $2,400,000 and Files for Conditional Approval

Thunder Bay, Ontario–(Newsfile Corp. – September 23, 2025) – Benton Resources Inc. (TSXV: BEX) (“Benton” or the “Company”) is pleased to announce that due to strong investor demand it has increased its non-brokered private placement, previously announced on September 17, 2025 (the “Financing”) to up to 43,636,364 $0.055 units (“Units”), for …

Read More »

Three Valley Copper Corp. Announces Extension of Loan Agreement

Toronto, Ontario–(Newsfile Corp. – September 23, 2025) – Three Valley Copper Corp. (TSXV: TVC) (the “Company“) is pleased to announce, further to its press release dated July 24, 2025, that it has formally extended the maturity date of the secured convertible promissory note dated July 25, 2023 (the “Promissory Note“) …

Read More »

Neural’s Partner Hanf.com Expands Retail Footprint with 17th Store Opening Near Munich

Toronto, Ontario–(Newsfile Corp. – September 23, 2025) – Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) (“Neural” or the “Company“), an ethnobotanical drug discovery company focused on developing therapeutic solutions for substance use disorders, together with CWE European Holdings Inc. (“CWE“), operating as Hanf.com, one of Germany’s leading CBD retailers, is …

Read More »

Hemostemix Files FDA Submission for Basket Protocol (Filing 1517) to Advance ACP-01 (VesCell(TM)) Across Multiple Ischemic and Vascular Indications Simultaneously

Calgary, Alberta–(Newsfile Corp. – September 23, 2025) – Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient’s own) stem cell therapy company offering VesCell™ (ACP-01) to no-option individuals suffering from peripheral arterial disease, chronic limb threatening ischemia, angina, ischemic cardiomyopathy, non-ischemic dilated cardiomyopathy, congestive heart failure, and …

Read More »